Total Health Conferencing’s 2022 Virtual ESMO Review will be a condensed review of the global meeting held earlier in September and will give healthcare providers the opportunity to learn about the latest advances in oncology education and translate science into better patient care. This meeting will facilitate the exchange and debate of translational cancer science…

FLASCO50 – 50% off of the registration fee for members Updates in Cancer Therapies: An ASCO/ESMO Review has been developed as a CE activity focusing on the highlights of recent developments presented at this year’s two important international congresses delivering a clear and high-quality comprehensive educational program with key opinion leaders in each cancer field. This…

This master lecture series will focus on providing comprehensive and latest oral and intravenous pharmacotherapy options for cancer patients.  With the exponential growth in the number of oncology pharmaceutical products available and increased innovation calling for utilization of multiple lines of therapy and expanding reliability on precision medicine to identify biomarker indicators to establish individualized,…

Join us at the Inaugural Miami Cancer Survivorship Symposium taking place on November 11, 2022, at the THēsis Hotel Miami. The event will feature speakers on survivorship topics ranging from symptom burden and quality of life in survivorship, disparities in survivorship outcomes, survivorship care coordination, and technology implementation in supportive and survivorship care delivery. Other…

This master lecture series will focus on providing comprehensive and latest oral and intravenous pharmacotherapy options for cancer patients.  With the exponential growth in the number of oncology pharmaceutical products available and increased innovation calling for utilization of multiple lines of therapy and expanding reliability on precision medicine to identify biomarker indicators to establish individualized,…

This master lecture series will focus on providing comprehensive and latest oral and intravenous pharmacotherapy options for cancer patients.  With the exponential growth in the number of oncology pharmaceutical products available and increased innovation calling for utilization of multiple lines of therapy and expanding reliability on precision medicine to identify biomarker indicators to establish individualized,…